RNASE3 and ankylosing spondylitis: In this regard, the detection of anti-ECP in our cohort may define a more precise patient group as all AEOSA+/ANCA− sera displaying both anti-EPX and anti-ECP reactivity appeared mainly in patients with either gastrointestinal tract inflammation and/or ankylosing spondylitis.